Fluticasone Furoate / Vilanterol (Breo Ellipta)

Inhaled corticosteroid (ICS) / long-acting beta2-adrenergic agonist (LABA) combination

Fluticasone Furoate / Vilanterol (Breo Ellipta)

Forms and strengths
Form: TabletStrength: 100 mcg/25 mcg, 200 mcg/25 mcg (fluticasone furoate/vilanterol per inhalation)
Print

Indication

  • Fluticasone furoate/vilanterol 100/25 mcg is used for the once-daily maintenance treatment of airflow obstruction in chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, and to reduce COPD exacerbations in patients with a history of exacerbations.
  • Fluticasone furoate/vilanterol 100/25 mcg and 200/25 mcg are used for the once-daily maintenance treatment of asthma in patients 18 years and older whose disease is not adequately controlled on an inhaled corticosteroid alone or whose severity warrants combined ICS/LABA therapy.
  • It is not intended to relieve sudden asthma or COPD symptoms and must not replace a fast-acting rescue inhaler.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.